Cargando…
Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter?
Pulmonary large cell neuroendocrine carcinoma (LCNEC) is rare. Chemotherapy for metastatic LCNEC ranges from small cell lung carcinoma (SCLC) regimens to nonsmall cell lung carcinoma (NSCLC) chemotherapy regimens. We analysed outcomes of chemotherapy treatments for LCNEC. The Netherlands Cancer Regi...
Autores principales: | Derks, Jules L., van Suylen, Robert Jan, Thunnissen, Erik, den Bakker, Michael A., Groen, Harry J., Smit, Egbert F., Damhuis, Ronald A., van den Broek, Esther C., Speel, Ernst-Jan M., Dingemans, Anne-Marie C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898951/ https://www.ncbi.nlm.nih.gov/pubmed/28572122 http://dx.doi.org/10.1183/13993003.01838-2016 |
Ejemplares similares
-
Is the sum of positive neuroendocrine immunohistochemical stains useful for diagnosis of large cell neuroendocrine carcinoma (LCNEC) on biopsy specimens?
por: Derks, Jules L, et al.
Publicado: (2019) -
Orthopedia Homeobox (OTP) in Pulmonary Neuroendocrine Tumors: The Diagnostic Value and Possible Molecular Interactions
por: Moonen, Laura, et al.
Publicado: (2019) -
Large cell neuroendocrine carcinoma with a solitary brain metastasis and low Ki-67: a unique subtype
por: Hermans, B C M, et al.
Publicado: (2019) -
In‐depth molecular analysis of combined and co‐primary pulmonary large cell neuroendocrine carcinoma and adenocarcinoma
por: Hermans, Bregtje C. M., et al.
Publicado: (2021) -
Development and verification of new monoclonal orthopedia homeobox (OTP) specific antibodies for pulmonary carcinoid diagnostics
por: Moonen, Laura, et al.
Publicado: (2022)